Results 221 to 230 of about 441,192 (316)
Effects of Effective Microorganism (EM) Inoculation on Co-Composting of <i>Auricularia heimuer</i> Residue with Chicken Manure and Subsequent Maize Growth. [PDF]
Feng Y +10 more
europepmc +1 more source
Natural products target the aging kidney in diabetic nephropathy by restoring the AMPK–SIRT1–Nrf2 axis, reducing oxidative stress, inflammation, fibrosis, and cellular senescence while enhancing mitochondrial biogenesis and antioxidant defenses.
Sherif Hamidu +8 more
wiley +1 more source
Diurnal differences in cerebral microvascular blood flow and oxygen delivery across brain regions in awake mice. [PDF]
Li B +13 more
europepmc +1 more source
Tracking Motor Progression and Device‐Aided Therapy Eligibility in Parkinson's Disease
ABSTRACT Objective To characterise the progression of motor symptoms and identify eligibility for device‐aided therapies in Parkinson's disease, using both the 5‐2‐1 criteria and a refined clinical definition, while examining differences across genetic subgroups.
David Ledingham +7 more
wiley +1 more source
Gravitational wave signatures of first-order phase transition in two-component dark matter model [PDF]
Seyed Yaser Ayazi +2 more
openalex +1 more source
Root-Canopy Coordination Drives High Yield and Nitrogen Use Efficiency in Dryland Winter Wheat. [PDF]
Li M +7 more
europepmc +1 more source
ABSTRACT Objective Cognitive impairment, fatigue, and depression are common in multiple sclerosis (MS), potentially due to disruption of regional functional connectivity caused by white matter (WM) lesions. We explored whether WM lesions functionally connected to specific brain regions contribute to these MS‐related manifestations.
Alessandro Franceschini +7 more
wiley +1 more source
Controlling the sign of optical forces using metaoptics. [PDF]
Afridi A, Melo B, Meyer N, Quidant R.
europepmc +1 more source
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini +13 more
wiley +1 more source

